Business Daily Media

Business Marketing

.

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan

  • Written by ACN Newswire - Press Releases

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan

TOKYO, Apr 23, 2021 - (JCN Newswire) - Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today an application submission in Japan for the additional indication of Eisai's in-house discovered and developed multiple receptor tyrosine kinase

Read more //?#

Popular

How To Improve Your Online Lessons

Teachers have had to make a huge adjustment in recent times due to the pandemic. The shift to online learning has been a massive challenge for both students and teachers alike, but you will find that remote learning is becomin...

Essential accounting tips for small business owners

Andy Richley, Marketing Manager at Khaos Cloud Accounting is unlikely to be your favourite part of running a business but it is crucial to your survival.   Running out of money is the reason 29% of startups fail, accordin...

Racing and Sports and Sky Racing World deal brings integrated form and vision package to US wagering operators

RAS Technology Holdings Limited (‘Racing and Sports’ or the ‘Company’) (ASX:RTH) is pleased to announce that Racing and Sports and Sky Racing World have expanded their partnership to bring a new and enhanced digital and media of...

Virtual Office
Tomorrow Business Growth